1. Medtech Insight
  3. >>Europe

Medtech Worried After UK HTA Body Moots Pharma Guidance Fees

 
• By Ashley Yeo

The UK health technology assessment body, NICE, has received its first reactions from a medtech industry association to proposals to raise fees from its program of pharma guidance. If, when or how quickly the medtech sector is fully impacted is a matter of concern across the SME-based industry.

UK medtech manufacturers have given their first consolidated response to the consultation issued by the National Institute for Health and Care Excellence (NICE) on its proposal to charge fees for guidance delivered.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe